Inhibition of EphB4-ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers
Cancer Research - United States
doi 10.1158/0008-5472.can-18-3257
Full Text
Open PDFAbstract
Available in full text
Date
March 20, 2019
Authors
Publisher
American Association for Cancer Research (AACR)